New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

Curated from NYT > Business — Here’s what matters right now:

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

Next step: Keep your day-to-day compliant and secure—find privacy-forward devices that help you stay protected.

Original reporting: NYT > Business

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.